MedPath

A Multicenter Study to Evaluate the ROX Arteriovenous Coupler in Patients With Treatment-Resistant Hypertension

Phase 3
Completed
Conditions
Hypertension
Registration Number
NCT01642498
Lead Sponsor
ROX Medical, Inc.
Brief Summary

The purpose of this study is to evaluate the safety and performance of the ROX COUPLER in patients with treatment-resistant hypertension.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Diagnosis of treatment-resistant hypertension must be made on the basis of current findings, medical history, and physical examination
Exclusion Criteria
  • Any serious medical condition that may adversely affect the patient's safety, limit the subject's ability to participate in the study, comply with follow-up requirements or impact the scientific integrity of the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Change in mean office SBPBaseline, 6 months

Change in mean office SBP at six months as compared to Baseline

Secondary Outcome Measures
NameTimeMethod
Change in mean office DBPBaseline, 6 months

Change in mean office DBP at six months as compared to Baseline

Trial Locations

Locations (18)

ZNA - Cardio Middleheim

🇧🇪

Antwerpen, Belgium

Universitair Ziekenhuis Brussel

🇧🇪

Brussels, Belgium

Universitätsmedizin Berlin - Campus Benjamin Franklin

🇩🇪

Berlin, Germany

Universitätsklinikum Erlangen

🇩🇪

Erlangen, Germany

Hypertoniezentrum Marburg

🇩🇪

Marburg, Germany

G. Gennimatas General Hospital of Athens

🇬🇷

Athens, Greece

Hippokration General Hospital of Athens

🇬🇷

Athens, Greece

Connolly Hospital

🇮🇪

Blanchardstown, Dublin, Ireland

Beaumont Hospital

🇮🇪

Dublin, Ireland

St. Antonius Ziekenhuis

🇳🇱

Nieuwegein, Netherlands

Scroll for more (8 remaining)
ZNA - Cardio Middleheim
🇧🇪Antwerpen, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.